Eugene Goldman

Eugene Goldman

McDermott Will & Schulte

Contact
View Bio
RSS

Latest Posts › Pharmaceutical Industry

Share:

New SEC Leadership Signals Continued Focus on FDA-Related Disclosures

Lawyers inside and outside the US Securities and Exchange Commission (SEC) have speculated that the agency’s new leadership will take a “lighter touch” when it comes to enforcement. The ultimate approach of the new SEC...more

3/21/2025  /  Disclosure Requirements , Enforcement Actions , Food and Drug Administration (FDA) , Insider Trading , Pharmaceutical Industry , Publicly-Traded Companies , Securities and Exchange Commission (SEC) , Securities Fraud , Securities Regulation
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide